CSB Genomika Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Early Stage VC
  • Financing Rounds
  • 2

CSB Genomika General Information

Description

Developer of a treatment for non-invasive cancer. The company provides personalized anticancer drug therapy for non-invasive cancer diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Parent Company
Primary Office
  • Moscow
  • Russia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CSB Genomika Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CSB Genomika‘s full profile, request access.

Request a free trial

CSB Genomika Executive Team (1)

Name Title Board Seat Contact Info
Vladislav Mileiko Managing Director & General Director
To view CSB Genomika’s complete executive team members history, request access »